Cocrystal Pharma Reports Third Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs
Go back to Cocrystal Pharma Reports Third Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs| Cocrystal Pharma, Inc. (NASDAQ: COCP) | Delayed: 1.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.00 | 52 Week High | $0.92 | |||
| Open | $1.00 | 52 Week Low | $0.32 | |||
| Day High | $1.04 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $-0.18 | |||
| Volume | 104,180 | |||||
